Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafluprost vs Latanoprost in newly-diagnosed glaucoma
NCT01433900Phase 3Unknown
- Start
- May 2012
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tafluprost in Glaucoma, ocular hypertension. Status: unknown.
02
Drugs
tafluprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT01433900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433900.